CTEV
Get informed when a big investor buys or sells
+ FollowOvervalued by 232.4% based on the discounted cash flow analysis.
| Market cap | $613.38 Million |
|---|---|
| Enterprise Value | $5.22 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-17.3 |
| Beta | 0.79 |
| Outstanding Shares | 16,964,960 |
| P/E Ratio | -2.12 |
|---|---|
| PEG | 38.81 |
| Price to Sales | 0.63 |
| Price to Book Ratio | -2.14 |
| Enterprise Value to Revenue | 5.25 |
| Enterprise Value to EBIT | 163.87 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | -15.69 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.6057▲ 106.21% |
|---|---|
| Total Calls | 60,100▼ 11.23% |
| Total Puts | 96,500▲ 162.23% |
Holdings and activity of institutional investors.
| Ownership % | 83.08%▼ 1.72% |
|---|---|
| Total Invested | $479.55M▲ 107.17% |
| Investors Holding | 113▲ 14.00% |
No data
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-...